Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04451863
Other study ID # 19-001519
Secondary ID R01AT010762
Status Recruiting
Phase Phase 1
First received
Last updated
Start date December 15, 2021
Est. completion date March 1, 2025

Study information

Verified date November 2023
Source University of California, Los Angeles
Contact Ziva Cooper, PhD
Phone 310-206-9942
Email zcooper@mednet.ucla.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this research is to assess the analgesic and subjective effects of terpenes administered alone and in combination of THC.


Description:

The overall aim of this placebo-controlled study is to examine dose-dependent analgesia, intoxication, abuse liability, and pharmacokinetics of ecologically relevant doses of vaporized myrcene and beta-caryophyllene administered alone or with vaporized THC.


Recruitment information / eligibility

Status Recruiting
Enrollment 45
Est. completion date March 1, 2025
Est. primary completion date October 15, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 21 Years to 55 Years
Eligibility Inclusion Criteria: - Male or non-pregnant female aged 21-55 years - Report non-medical use of cannabis 1-7 days per week over the 1 month prior to screening - Not currently seeking treatment for cannabis use - Urine test positive for recent cannabis use - Have a Body Mass Index from 18.5 - 34kg/m2. - Able to perform all study procedures - Must be using a contraceptive method (hormonal or barrier methods) Exclusion Criteria: - Meeting DSM-V criteria for any substance use disorder other than nicotine, caffeine, or mild CUD - Report using other illicit drugs in the prior 4 weeks - • If medical history, physical and psychiatric examination, or laboratory tests performed during the screening process not within the normal range and / or reveal any significant illness (e.g., hypertension) as judged by the study physician and to put the participant at greater risk of experiencing adverse events due to completion of study procedures. - Current licit use of cannabis primarily for medical purposes, prescription analgesics, or any medications that may affect study outcomes - Current pain - Pregnancy is exclusionary due to the possible effects of the study medication on fetal development. - History of an allergic reaction or adverse reaction to cannabis is exclusionary. - History of respiratory illness or current respiratory illness - History of seizure disorder or current seizure disorder - Insensitivity to the cold water stimulus of the Cold Pressor Test - Currently enrolled in another research protocol - Current major Axis 1 disorders (mood, anxiety, or psychotic disorder) - Not using a contraceptive method (hormonal or barrier methods) - The evaluating physician reviews all medical assessments along with medical history. Any disorders that might make cannabis administration hazardous are exclusionary.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Low THC
Vaporized THC (5 mg)
High THC
Vaporized THC (15 mg)
Low Myrcene
Vaporized Myrcene (0.5 mg)
High Myrcene
Vaporized Myrcene (12.0 mg)
Low Beta-Caryophyllene
Vaporized Beta-Caryophyllene (0.5 mg)
High Beta-Caryophyllene
Vaporized Beta-Caryophyllene (7.5 mg)
Placebo
Vaporized Placebo

Locations

Country Name City State
United States University of California, Los Angeles Los Angeles California

Sponsors (2)

Lead Sponsor Collaborator
University of California, Los Angeles National Center for Complementary and Integrative Health (NCCIH)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Analgesia as measured using the Cold Pressor Test Pain threshold and pain tolerance assessed using the Cold Pressor Test 7 hours
Primary Subject-rated drug effects of abuse liability Subject ratings of "Good Drug Effect" as measured using a visual analog scale (1-100 mm) 7 hours
Secondary Subject-rated drug effects of intoxication Subject ratings of "High" as measured using a visual analog scale (1-100 mm) 7 hours
Secondary Subjective ratings of pain Subject ratings of Painfulness and Bothersomeness of the Cold Pressor Test 7 hours
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05559255 - Changes in Pain, Spasticity, and Quality of Life After Use of Counterstrain Treatment in Individuals With SCI N/A
Completed NCT04748367 - Leveraging on Immersive Virtual Reality to Reduce Pain and Anxiety in Children During Immunization in Primary Care N/A
Terminated NCT04356352 - Lidocaine, Esmolol, or Placebo to Relieve IV Propofol Pain Phase 2/Phase 3
Completed NCT05057988 - Virtual Empowered Relief for Chronic Pain N/A
Completed NCT04466111 - Observational, Post Market Study in Treating Chronic Upper Extremity Limb Pain
Recruiting NCT06206252 - Can Medical Cannabis Affect Opioid Use?
Completed NCT05868122 - A Study to Evaluate a Fixed Combination of Acetaminophen/Naproxen Sodium in Acute Postoperative Pain Following Bunionectomy Phase 3
Active, not recruiting NCT05006976 - A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study N/A
Completed NCT03273114 - Cognitive Functional Therapy (CFT) Compared With Core Training Exercise and Manual Therapy (CORE-MT) in Patients With Chronic Low Back Pain N/A
Enrolling by invitation NCT06087432 - Is PNF Application Effective on Temporomandibular Dysfunction N/A
Completed NCT05508594 - Efficacy and Pharmacokinetic-Pharmacodynamic Relationship of Intranasally Administered Sufentanil, Ketamine, and CT001 Phase 2/Phase 3
Recruiting NCT03646955 - Partial Breast Versus no Irradiation for Women With Early Breast Cancer N/A
Active, not recruiting NCT03472300 - Prevalence of Self-disclosed Knee Trouble and Use of Treatments Among Elderly Individuals
Completed NCT03678168 - A Comparison Between Conventional Throat Packs and Pharyngeal Placement of Tampons in Rhinology Surgeries N/A
Completed NCT03931772 - Online Automated Self-Hypnosis Program N/A
Completed NCT03286543 - Electrical Stimulation for the Treatment of Pain Following Total Knee Arthroplasty Using the SPRINT Beta System N/A
Completed NCT02913027 - Can We Improve the Comfort of Pelvic Exams? N/A
Terminated NCT02181387 - Acetaminophen Use in Labor - Does Use of Acetaminophen Reduce Neuraxial Analgesic Drug Requirement During Labor? Phase 4
Recruiting NCT06032559 - Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment Phase 3
Active, not recruiting NCT03613155 - Assessment of Anxiety in Patients Treated by SMUR Toulouse and Receiving MEOPA as Part of Their Care